Hepatitis Clinical Trials

Showing 1601-1620 of 1,819 trials

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

NCT00558493

A multi-center and open study to compare the safety and effectiveness of switching treatment from lamivudine to clevudine for 24 weeks.

Chronic Hepatitis B

Bukwang Pharmaceutical100 participantsStarted Nov 2007

Daegu, South Korea

COMPLETEDPhase 3

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

NCT00362635

The purpose of this study is to compare the efficacy and safety of 48-week treatment with Clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection.

Hepatitis B

Bukwang Pharmaceutical92 participantsStarted Aug 2006

Tai Po, New Territories, Hong Kong • Road, Hong Kong

COMPLETEDPhase 4

Long-term Study With Clevudine

NCT00558818

A open-labeled phase lV study with 96 weeks of treatment period. The purpose of this study is to investigate safety and efficacy of clevudine in patients chronically infected with hepatitis B virus, HBeAg positive or negative.

Chronic Hepatitis B

Bukwang Pharmaceutical150 participantsStarted Jun 2007

Seoul, South Korea

COMPLETEDPhase 1

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

NCT01250366

The purpose of this study is to determine the Safety and Pharmacokinetics of Multiple Ascending Oral Doses of INX-08189 in Chronically-infected Genotype 1 HCV, Treatment-naïve Subjects.

HCV (Genotype 1)

Bristol-Myers Squibb70 participantsStarted Oct 2010

Los Angeles, California, United States • Plymouth, Minnesota, United States • San Antonio, Texas, United States +1 more locations

Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection

Long-term Study With Clevudine

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Related Searches

Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease

A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive

Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive

Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Open-Label Hepatic Impairment Study

A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals

Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected Adults

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV

Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B

Treatment of Recurrent Hepatitis C After Liver Transplantation

A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.

A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients